Menu
Recruiting NCT07199751

Comparison of Complication Rate, Functional Outcome and Quality of Life Between Standard Therapy Versus Fast-track Therapy in Patients Following Hip Replacement Surgery

Observational Coxarthrosis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Coxarthrosis. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Vergleich Der Komplikationsrate, Des Funktionellen Outcomes Und Der Lebensqualität Zwischen Standard Therapie Versus Fast Track Therapie Bei Patienten Und Patientinnen Nach Hüft-TEP Operationen

Overview

The fast track group vs. control group will be compared with regard to hospitalization time and the non-inferiority of the fast track group vs. control group with regard to HOOS will be assessed. The questionnaires will only be collected in the study: Eq-5d-5l, HOOS, self-efficacy, enjoyment of movement, fear of movement, pain catastrophizing.

Detailed description

Around 400,000 hip and knee endoprostheses are implanted in Germany every year. Due to demographic change, the trend is clearly on the rise, which also results in rising costs in this area for the solidarity community. The Clinic for Orthopaedics and Sports Orthopaedics at the TUM Clinic is about to implement the Fast Track method after total hip arthroplasty (THA, in German: Hüft-TEP). The aim of this method is to shorten the length of stay in hospital and the post-operative recovery time as well as to promote rapid mobilization and independence of patients without worsening the functional outcome or the complication rate. The investigators will therefore investigate the extent to which it is possible to reduce the length of hospital stay without compromising function.

* Primary endpoints: Hospital length of stay, HOOS. * Secondary endpoints: PROMs Quality of life Eq-5d-5l (EuroQol 5 dimensions Lang) Function Mobility (TUG test) in seconds Pain (NRS), ROM (neutral zero method), Strength (Nm/kg body weight, muscle function test) Self-efficacy/ pleasure/ fear of movement/pain catastrophizing Exercise self efficacy scale (ESES), physical activity enjoyment scale (PACES), Kinesiophobia (TSK), Pain catastrophizing scale (PCS).

With an original length of stay of 6 days and a target length of stay of 4 days, the expected reduction is 2 days. A standard deviation of 3 days is assumed in both groups (calculations based on patient data from August to December 2024) and a significance level of 0.05 and power of 80% are assumed. The required number of cases is therefore at least 36 participants per group. With this number of cases, the non-inferiority of the fast-track method compared to the standard method with regard to HOOS can also be demonstrated with a probability of 80%, assuming that the true mean difference between the methods is 0 points and the standard deviation for both methods is 15 points (Δ = 10 points, one-sided 97.5% confidence interval). To compensate for a potential drop-out rate, 45 patients per group should be recruited. With a primary hip TEP (THA) surgery rate of approx. 10 patients per week (cf. 2024) and a 2-month duration per group, the investigators can recruit a maximum of 80 patients per group. The investigators are therefore confident that the required case number of 45 per group will be reached.

Primary outcome measures

  • Hospital length of stay (days) [Time frame: From day of surgery until discharge, up to 4 days post-surgery]
  • Hip Disability and Osteoarthritis Outcome Score (HOOS) [Time frame: From baseline (pre-surgery) to 3 months post-surgery]
Secondary outcome measures (8)
  • Timed Up and Go (TUG) Test [Time frame: From baseline (pre-surgery) to 3 months post-surgery]
  • EQ-5D-5L (EuroQol 5 Dimensions, 5 Levels) [Time frame: From baseline (pre-surgery) to 3 months post-surgery]
  • Range of Motion (ROM) - Neutral Zero Method (degrees) [Time frame: From baseline (pre-surgery) to 3 months post-surgery]
  • Exercise Self-Efficacy Scale (ESES) [Time frame: From baseline (pre-surgery) to 3 months post-surgery]
  • Pain Catastrophizing Scale (PCS) [Time frame: From baseline (pre-surgery) to 3 months post-surgery]
  • Tampa Scale for Kinesiophobia (TSK) [Time frame: From baseline (pre-surgery) to 3 months post-surgery]
  • Muscle Strength (Nm/kg body weight) [Time frame: From baseline (pre-surgery) to 3 months post-surgery]
  • Physical Activity Enjoyment Scale (PACES) [Time frame: From baseline (pre-surgery) to 3 months post-surgery]

Eligibility criteria

Inclusion criteria

  • Age ≥18 years
  • The patient will undergo surgery at Klinikum rechts der Isar, Technical University of Munich (TUM)
  • Written informed consent for participation in the study after detailed explanation of the nature, significance, risks and scope of the clinical trial
  • Written informed consent from the patient for data collection and data processing, with the patient fully informed.
  • Sufficient German language skills of the patient.

Exclusion criteria

  • Age < 18 years
  • The patient is under guardianship, legally incapacitated or has limited legal capacity
  • Only partial weight-bearing permitted

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

Germany · 1 center
  • Department Physical Therapy — München

Identifiers

NCT: NCT07199751 · 2025-155-S-CB

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗